Partnerships & Mergers

This collaboration delivers crucial funding to Agenus while simultaneously securing sustained biologics manufacturing capacity within the United States.

The companies unveiled their partnership at the 2026 J.P. Morgan Healthcare Conference, which took place from January 12 to 15 in San Francisco.

Nimbus will leverage its specialized expertise in computational chemistry and structure-based drug design to discover a small molecule drug candidate.

The continued partnership aims to strengthen research focused on developing effective therapeutic options for mpox, a viral disease that currently lacks a dedicated antiviral treatment.

Sanofi will leverage Earendil’s artificial intelligence (AI)-powered drug discovery platform to support the design and development of multiple new therapeutic assets.

Before this partnership, JOOTRH referred radiotherapy cases to Kenyatta National Hospital (KNH) or Moi Teaching and Referral Hospital (MTRH).

The upgraded laboratory streamlines sample processing from reception through advanced analysis and genetic sequencing.

This initiative aligns with the Ministry’s National Cancer Plan 2023–2028 and represents a key step in advancing Lebanon’s cancer control strategy.

This partnership marks a major step in advancing clinical excellence, operational efficiency, and innovation in one of the Middle East’s most rapidly evolving medical markets.

This new alliance stands out as a bold and unconventional initiative that blends healthcare innovation with creative design thinking.